Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The objective of this work was to thoroughly examine the smooth muscle relaxing properties of cinnamedrine, compared with papaverine, in vitro, using rat uterus.
Cinnamedrine
and papaverine both exhibited dose-related spasmolytic activity in the isolated spontaneously contracting rat uterus and in uterine tissue pretreated with
oxytocin
to augment spasms. The IC50's for cinnamedrine and papaverine were 36.2 and 7.7 microM respectively; the IC50's after
oxytocin
pretreatment were 25.7 microM for cinnamedrine and 10.0 microM for papaverine. Neither hormonal status of the rats, with respect to their estrus cycle, nor
oxytocin
pretreatment of the isolated tissues noticeably affected the activity of either cinnamedrine or papaverine.
...
PMID:Spasmolytic activity of cinnamedrine and papaverine in isolated rat uterine muscle. 661 77